Form 8-K - Current report:
SEC Accession No. 0001104659-25-022423
Filing Date
2025-03-11
Accepted
2025-03-11 08:05:38
Documents
15
Period of Report
2025-03-11
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm258742d3_8k.htm   iXBRL 8-K 26176
2 EXHIBIT 99.1 tm258742d3_ex99-1.htm EX-99.1 12319
6 GRAPHIC tm258742d3_ex99-1img001.jpg GRAPHIC 7004
  Complete submission text file 0001104659-25-022423.txt   228297

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA sgmt-20250311.xsd EX-101.SCH 3012
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE sgmt-20250311_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sgmt-20250311_pre.xml EX-101.PRE 22357
17 EXTRACTED XBRL INSTANCE DOCUMENT tm258742d3_8k_htm.xml XML 3815
Mailing Address 155 BOVET RD., SUITE 303 SAN MATEO CA 94402
Business Address 155 BOVET RD., SUITE 303 SAN MATEO CA 94402 (650) 561-8600
Sagimet Biosciences Inc. (Filer) CIK: 0001400118 (see all company filings)

EIN.: 205991472 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41742 | Film No.: 25725905
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)